{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihraazk7liywepfra52rctn4xvc74m5zlar67zbrgmcqjxldfi45e",
    "uri": "at://did:plc:svcthvzunxmjidtlw23zva6n/app.bsky.feed.post/3mexkj7qmikz2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreib5yaqgpd5w3f3ov63u2ct26wnpso455d3grel3lcafrghhi5glwi"
    },
    "mimeType": "image/jpeg",
    "size": 7220
  },
  "path": "/2026/02/16/quidelortho-enters-strategic-supply-agreement-to-expand-global-immunoassay-portfolio/",
  "publishedAt": "2026-02-16T06:00:00.000Z",
  "site": "https://laotiantimes.com",
  "tags": [
    "Cision PR Newswire"
  ],
  "textContent": "Agreement adds new analyzer platforms and expands assay menu across key international markets SAN DIEGO, Feb. 16, 2026 /PRNewswire/ — QuidelOrtho has entered a long-term strategic supply agreement with Lifotronic Technology Co., Ltd. (Lifotronic Technology Co., Ltd., stock code: 688389), to expand QuidelOrtho’s global immunoassay portfolio and accelerate customer access to scalable, high quality, cost-efficient […]",
  "title": "QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio"
}